Modulation of synovial cell function by somatostatin in patients with rheumatoid arthritis

Arthritis and Rheumatism

Volumn 40, Issue 12, 1997, Pages 2128-2138

  Takeba, Yuko ^a   Suzuki, Noboru ^a   Takeno, Mitsuhiro ^a   Asai, Tomiaki ^b   Tsuboi, Seiji ^b   Hoshino, Takashi ^a   Sakane, Tsuyoshi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COMPLEMENTARY DNA; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTHRITIS; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLAMMATION; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

ACTIVATING TRANSCRIPTION FACTOR 1; ADULT; AGED; ARTHRITIS, RHEUMATOID; CELL DIVISION; CELLS, CULTURED; COLLAGENASES; CYTOKINES; DNA PRIMERS; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; RECEPTORS, SOMATOSTATIN; RNA, MESSENGER; SOMATOSTATIN; SYNOVIAL MEMBRANE; TRANSCRIPTION FACTORS;

EID: 0031457581     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780401206     Document Type: Article

References (55)

1. Harris ED Jr: Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 322:1277-1289, 1990
2. Cash JM, Klippel JH: Second-line drug therapy for rheumatoid arthritis. N Engl J Med 330:1368-1375, 1994
3. Panayi GS. Lanchbury JS, Kingsley GH: The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 35:729-735, 1992
4. Zvaifler NJ, Firestein GS: Pannus and pannocytes: alternative models of joint destruction in rheumatoid arthritis. Arthritis Rheum 37:783-789, 1994
5. 2 production by human synovial cells. J Clin Invest 77:645-648, 1986
6. Meyer FA, Yaron I, Yaron M: Synergistic, additive, and antagonistic effects of interleukin-1β, tumor necrosis factor α, and γ-interferon on prostaglandin E, hyaluronic acid, and collagenase production by cultured synovial fibroblasts. Arthritis Rheum 33: 1518-1525, 1990
7. Woessner JF Jr: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154, 1991
8. Butler DM, Piccoli DS, Hart PH, Hamilton JA: Stimulation of human synovial fibroblast DNA synthesis by recombinant human cytokines. J Rheumatol 15:1463-1470, 1988
9. Baker GHB: Life events before the onset of rheumatoid arthritis. Psychother Psychosom 38:173-177, 1982
10. Wilder RL: Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 13:307-338, 1995
11. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R: Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179:77-79, 1973
12. Vale W, Ling N, Rivier J, Villarreal J, Rivier C, Douglas C, Brown M: Anatomic and phylogenetic distribution of somatostatin. Metabolism 25 (suppl 1):1491-1494, 1976
13. Karalis K, Mastorakos G, Chrousos GP, Tolis G: Somatostatin analogues suppress the inflammatory reaction in vivo. J Clin Invest 93:2000-2006, 1994
14. Kolasinski SL, Haines KA, Siegel EL, Cronstein BN, Abramson SB: Neuropeptides and inflammation: a somatostatin analog as a selective antagonist of neutrophil activation by substance P. Arthritis Rheum 35:369-375, 1992
15. Hahener JF, Meyer TE, Yun Y, Wacher G, Hoeffler JP: Characterization of a cAMP-regulated enhancer-binding protein. Metabolism 39 (suppl 2): 13-16, 1990
16. Matucci-Cerinic M, Borrelli F, Generini S, Cantelmo A, Marcucci I, Martclli F, Romagnoli P, Bacci S, Conz A, Marinclli P, Marabini S: Somatostatin-induced modulation of inflammation in experimental arthritis. Arthritis Rheum 38:1687-1693, 1995
17. Rcubi JC, Mazzucchelli L, Laissue JA: Intestinal vessels express a high density of somatostatin receptors in human inflammatory bowel disease. Gastroenterology 106:951-959, 1994
18. Sicuteri F, Geppetti P, Marabini S, Lembeck F: Pain relief by somatostatin in attacks of cluster headache. Pain 18:359-365, 1984
19. Chrubasik J, Meynadier J, Blond S, Scherpereel P, Ackerman E, Weinstock M, Bonath K, Cramer H, Wünsch E: Somatostatin, a potent analgesic. Lancet 11:1208-1209, 1984
20. Matucci-Cerinic M, Lotti T, Cappugi P, Boddi V, Fattorini L, Panconesi E: Somatostatin treatment of psoriatic arthritis. Int J Dermatol 27:56-58, 1988
21. Matucci-Cerinic M, Marabini S: Somatostatin treatment for pain in rheumatoid arthritis: a double blind versus placebo study in knee involvement. Mcd Sci Res 16:233-234, 1988
22. Coari G, Di Franco M, Iagnocco A, Di Novi MR, Mauceri MT, Ciocci A: Intra-articular somatostatin 14 reduces synovial thickness in rheumatoid arthritis: an ultrasonographic study. Int J Clin Pharmacol Res 15:27-32, 1995
23. Fioravanti A, Govoni M, La Montagna G, Perpignano G, Tirri G, Trotta F, Bogliolo A, Ciocci A, Mauceri MT, Marcolongo R: Somatostatin 14 and joint inflammation: evidence for intraarticular efficacy of prolonged administration in rheumatoid arthritis. Drugs Exp Clin Res 21:97-103, 1995
24. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
25. Martel-Pelletier J, Cloutier J-M. Pelletier J-P: In vivo effects of antirheumatic drugs on neutral collagenolytic proteases in human rheumatoid arthritis cartilage and synovium. J Rheumatol 15: 1198-1204, 1988
26. Mochizuki M, Suzuki N, Takeno M, Nagafuchi H, Harada T, Kaneoka H, Yamashita N, Hirayama K, Nakajima T, Mizushima Y, Yamamoto S, Sakane T: Fine antigen specificity of human γδ T cell lines (Vγ9+) established by repetitive stimulation with a serotype (KTH-1) of a gram-positive bacterium, Streptococcus sanguis. Eur J Immunol 24:1536-1543, 1994
27. Bost KL, Mason MJ: Thapsigargin and cyclopiazonic acid initiate rapid and dramatic increases of IL-6 mRNA expression and IL-6 secretion in murine peritoneal macrophages. J Immunol 155:285296, 1995
28. Chong C, Bost KL, Clements JD: Differential production of interleukin-12 mRNA by murine macrophages in response to viable or killed Salmonella spp. Infect Immun 64:1154-1160, 1996
29. Kincy-Cain T, Bost KL: Substance P-induced IL-12 production by murine macrophages. J Immunol 158:2334-2339, 1997
30. Zhang CY, Yokogoshi Y, Yoshimoto K, Fujinaka Y, Matsumoto K, Saito S: Point mutation of the somatostatin receptor 2 gene in the human small cell lung cancer cell line COR-L103. Biochem Biophys Res Commun 210:805-815, 1995
31. Shen L-P, Pictet RL, Rutter WJ: Human somatostatin I: sequence of the cDNA. Proc Natl Acad Sci U S A 79:4575-4579, 1982
32. Grönblad M, Konttinen YT, Korkala O, Liesi P, Hukkanen M, Polak JM: Neuropeptides in synovium of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 15:1807-1810, 1988
33. Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489, 1983
34. Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S: Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci U S A 89:251-255, 1992
35. Corness JD, Demchyshyn LL, Seeman P, van Tol HHM, Srikant CB, Kent G, Patel YC, Niznik HB: A human somatostatin receptor (SSTR3), located on chromosome 22, displays preferential affinity for somatostatin-14 like peptides. FEBS Lett 321:279-284, 1993
36. Demchyshyn LL, Srikant CB, Sunahara RK, Kent G, Seeman P, van Tol HHM, Panetta R, Patel YC, Niznik HB: Cloning and expression of a human somatostatin-14-selective receptor variant (somatostatin receptor 4) located on chromosome 20. Mol Pharmacol 43:894-901, 1993
37. Yamada Y, Kagimoto S, Kubota A, Yasuda K, Masuda K, Someya Y, Ihara Y, Li Q, Imura H, Seino S, Seino Y: Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. Biochem Biophys Res Commun 195:844-852, 1993
38. Feldmann M, Brennan FM, Maini RN: Rheumatoid arthritis. Cell 85:307-310, 1996
39. McCarty DJ, Koopman WJ, editors: Arthritis and Allied Conditions: A Textbook of Rheumatology. Twelfth edition. Philadelphia, Lea & Febiger, 1993
40. Walsh DA, Mapp PI, Wharton J, Polak JM, Blake DR: Neuropeptide degrading enzymes in normal and inflamed human synovium. Am J Pathol 142:1610-1621, 1993
41. Lilly CM, Kobzik L, Hall AE, Drazen JM: Effects of chronic airway inflammation on the activity and enzymatic inactivation of neuropeptides in guinea pig lungs. J Clin Invest 93:2667-2674, 1994
42. Lotz M, Carson DA, Vaughan JH: Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science 235:893-895, 1987
43. Patel YC, Murthy KK, Escher EE, Banville D, Spiess J, Srikant CB: Mechanism of action of somatostatin: an overview of receptor function and studies of the molecular characterization and purification of somatostatin receptor proteins. Metabolism 39 (suppl 2):63-69, 1990
44. Kimata H, Yoshida A, Fujimoto M, Mikawa H: Effect of vasoactive intestinal peptide, somatostatin, and substance P on spontaneous IgE and IgG4 production in atopic patients. J Immunol 150:4630-4640, 1993
45. Payan DG, Hess CA, Goetzl EJ: Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts. Cell Immunol 84:433-438, 1984
46. Goetzl EJ, Payan DG: Inhibition by somatostatin of the release of mediators from human basophils and rat leukemic basophils. J Immunol 133:3255-3259, 1984
47. Karalis K, Mastorakos G, Sano H, Wilder RE, Chrousos GP: Somatostatin may participate in the antiinflammatory actions of glucocorticoids. Endocrinology 136:4133-4138, 1995
48. Gagel RF, Palmer WN, Leonhart K, Chan L, Leong SS: Somatostatin production by a human medullary thyroid carcinoma cell line. Endocrinology 118:1643-1651, 1986
49. Cote GJ, Palmer WN, Leonhart K, Leong SS, Gagel RF: The regulation of somatostatin production in human medullary thyroid carcinoma cells by dexamethasone. J Biol Chem 261:12930-12935, 1986
50. Reubi JC, Waser B, Horisberger U, Krenning E, Lamberts SWJ, Gebbers J-O, Gersbach P, Laissue JA: In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue. Blood 82:2143-2151, 1993
51. Hiruma K, Koike T, Nakamura H, Sumida T, Maeda T, Tomioka H, Yoshida S, Fujita T: Somatostatin receptors on human lymphocytes and leukemia cells. Immunology 71:480-485, 1990
52. Reubi JC, Waser B, Markusse HM, Krenning EP, Vanhagen M, Laissue JA: Vascular somatostatin receptors in synovium from patients with rheumatoid arthritis. Eur J Pharmacol 271:371-378, 1994
53. Vanhagen PM, Markusse HM, Lamberts SWJ, Kwekkeboom DJ, Reubi JC, Krenning EP: Somatostatin receptor imaging: the presence of somatostatin receptors in rheumatoid arthritis. Arthritis Rheum 37:1521-1527, 1994
54. Rcisine T: Somatostatin desensitization: loss of the ability of somatostatin to inhibit cyclic AMP accumulation and adrenocorticotropin hormone release. J Pharmacol Exp Ther 229:14-20, 1983
55. Lorenz JJ, Furdon PJ, Taylor JD, Verghese MW, Chandra G, Kost TA, Haneline SA, Roner LA, Gray JG: A cyclic adenosine 3′,5′-monophosphate signal is required for the induction of IL-1β by TNFα in human monocytes. J Immunol 155:836-844, 1995